Clindamycin Phosphate
- Chemical Name:Clindamycin phosphate
- CAS No.:24729-96-2
- MF: C18H34ClN2O8PS
- MW:504.96
- Specification: USP|EP|BP
- Purity: >95% or As customer requested
- Solubility:Freely soluble in water
- Product Categories:Antibiotics;Chiral Reagents;Intermediates & Fine Chemicals;Pharmaceuticals
- Test method: HPLC
Description
Clindamycin Phosphate is the phosphate salt form of clindamycin, a semi-synthetic, chlorinated broad spectrum antibiotic produced by chemical modification of lincomycin. Clindamycin phosphate is used in topical preparations.
Clindamycin phosphate Basic information
Product Name: | Clindamycin phosphate |
Synonyms: | (2s-trans)-;2-(dihydrogenphosphate;U-28508E; Clindamycin phosphate BP98,USP25,EP97; Clindaymcin Palmitate hydrochloride USP23; L-threo-.alpha.-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(2S,4R)-1-methyl-4-propyl-2-pyrrolidinylcarbonylamino-1-thio-, 2-(dihydrogen phosphate); CLINDAMYCINPHOSPHATE,CRYSTAL,USP; CLINDAMYCIN PHOSPHATE/ 7-(S)-CHLORO-7-DEOXY-LINCOMYCIN-2-ORGANIC PHOSPHATE |
CAS: | 24729-96-2 |
MF: | C18H34ClN2O8PS |
MW: | 504.96 |
EINECS: | 246-433-0 |
Product Categories: | API’s; Intermediates & Fine Chemicals; Antibiotics for Research and Experimental Use; Pharmaceuticals |
Mol File: | 24729-96-2.mol |
Clindamycin phosphate Chemical Structure
Cleocin t Chemical Properties
Melting point | 114 °C |
Boiling point | 159°C |
density | 1.41±0.1 g/cm3(Predicted) |
refractive index | 122 ° (C=1, H2O) |
storage temp. | 2-8°C |
solubility | DMSO: soluble224mg/mL at 25°C |
form | solid |
pka | pKa 0.964±0.06 (H2O t=21) (Uncertain);6.06 ±0.06 (I=0.008)(H2O t=21) (Uncertain) |
Water Solubility | Freely soluble in water |
Merck | 14,2356 |
Stability: | Stable, but store cool. Incompatible with strong oxidizing agents, calcium gluconate, barbiturates, magnesium sulfate, phenytoin, B group sodium vitamins. |
Cleocin t Usage And Synthesis
Uses | Clindamycin phosphate is used topically alone or in conjunction with benzoyl peroxide in the treatment of inflammatory acne vulgaris. In weighing the potential benefits of topical clindamycin therapy, the possibility of serious adverse GI effects associated with the drug should be considered. Therapy of acne vulgaris must be individualized and frequently modified depending on the types of acne lesions which predominate and the response to therapy. Topical anti-infectives, including clindamycin, generally are effective in the treatment of mild to moderate inflammatory acne. However, use of topical anti-infectives as monotherapy may lead to bacterial resistance; this resistance is associated with decreased clinical efficacy.Topical clindamycin is particularly useful when used with benzoyl peroxide or topical retinoids. Results of clinical studies indicate that combination therapy results in a reduction in total lesion counts of 50-70%. |
MSDS: MSDS available
COA: COA can be available if you send us inquiry.
Email us at: info@maxmedchem.com for more details.